Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - IMMUNE PHARMACEUTICALS INCFinancial_Report.xls
EX-31.1 - EXHIBIT 31.1 - IMMUNE PHARMACEUTICALS INCv405335_ex31-1.htm
EX-31.2 - EXHIBIT 31.2 - IMMUNE PHARMACEUTICALS INCv405335_ex31-2.htm
EX-32.1 - EXHIBIT 32.1 - IMMUNE PHARMACEUTICALS INCv405335_ex32-1.htm
EX-23.1 - EXHIBIT 23.1 - IMMUNE PHARMACEUTICALS INCv405335_ex23-1.htm
EX-10.42 - EXHIBIT 10.42 - IMMUNE PHARMACEUTICALS INCv405335_ex10-42.htm
EX-10.38 - EXHIBIT 10.38 - IMMUNE PHARMACEUTICALS INCv405335_ex10-38.htm
EX-10.41 - EXHIBIT 10.41 - IMMUNE PHARMACEUTICALS INCv405335_ex10-41.htm
10-K - FORM 10-K - IMMUNE PHARMACEUTICALS INCv405335_10k.htm
EX-32.2 - EXHIBIT 32.2 - IMMUNE PHARMACEUTICALS INCv405335_ex32-2.htm

 

Exhibit 21.1

 

Subsidiaries of Immune Pharmaceuticals Inc.

 

The following are the subsidiaries of Immune Pharmaceuticals Inc.:

 

Name   Jurisdiction of Incorporation
Immune Pharmaceuticals USA Corp.   Delaware
Immune Pharmaceuticals Ltd.   Israel
Maxim Pharmaceuticals, Inc.   Delaware
Cytovia, Inc.   Delaware
EpiCept GmbH (in liquidation)   Germany